Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Clinical trial NCT06022289 · UNKNOWN

Trial details

NCT number: NCT06022289
Sponsor: Tianjin Medical University Second Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor FGF Receptor Gene Mutation FGF Amplification FGF Receptor Gene Family Rearrangement FGF Receptor Gene Translocation

Start date: 2023-05-01
Primary completion: 2025-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.